Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemiaAlberto Álvarez‐Larrán, Carlos Besses, Carmen Burgaleta et al.|Blood|2010Cited by 233
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrđan Verstovšek, Claire Harrison, Ruben A. Mesa et al.|Blood Advances|2023Cited by 48
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)Cristina Astrid Tentori, Najla H. Al Ali, Caterina Gregorio et al.|Blood|2023Cited by 5
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)Luca Lanino, Vladan Vučinić, Anthony M. Hunter et al.|Blood|2024Cited by 3
Artificial-Intelligence, Data-Driven, Comprehensive Classification of Myeloid Neoplasms Based on Genomic, Morphological and Histological FeaturesLuca Lanino, David Quintela, Saverio D’Amico et al.|Blood|2024Cited by 2